Nectar Lifesciences Ltd - 532649 - Compliance Certificate U/R 7(3) For The Half Year Ended On March 31, 2019
Compliance certificate under regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for the half year ended on March 31, 2019. NECTAR LIFESCIENCES LTD. - 532649 - CERTIFICATE U/R 40(9) OF SEBI (LODR) REGULATIONS, 2015
CERTIFICATE UNDER REGULATION 40 (9) OF SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURES REQUIREMENT) REGULATIONS, 2015 FOR THE HALF YEAR ENDED ON MARCH 31, 2019. Nectar Lifesciences Ltd - 532649 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- Ankita JainDesignation :- Company Secretary and Compliance Officer NECTAR LIFESCIENCES LTD. - 532649 - Closure of Trading Window
Notice of Closure of Trading Window as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Resignation of Director
Mr. Harparkash Singh Gill (DIN: 06414839) has resigned as a Director as well as the Whole Time Director of the Company w.e.f. February 28, 2019. Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are furnishing herewith newspaper cuttings of Financial Results of the Company for the period ended on December 31, 2018, which have been published in the following newspapers: 1. Business Standard (English-all editions) dated 12.02.2019 2. Desh Sewak (Punjabi) dated 12.02.2019 NECTAR LIFESCIENCES LTD. - 532649 - Outcome of Board Meeting
Outcome of Board of Directors in their meeting held on February 11, 2019 Nectar Lifesciences Ltd - 532649 - Un-Audited Standalone Financial Results For The Quarter & Nine Months Period Ended On December 31, 2018 And Limited Review Report
The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Un-audited Standalone Financial results for the quarter & nine months period ended on December 31, 2018 which are enclosed herewith along with the Limited Review Report of the Auditors thereon. Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are furnishing herewith newspaper cutting of Notice of Board Meeting of the company scheduled to be held on February 11, 2019 which has been published in the following newspapers: 1. Business Standard (English-all editions) dated 05.02.2019. 2. Desh Sewak (Punjabi) dated 05.02.2019 Nectar Lifesciences Ltd - 532649 - Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2019 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board of Directors of the company will be held on Monday, 11th February, 2019 to consider and approve, inter alia amongst items the Unaudited Financial Results for the quarter & Nine Months ended on December 31, 2018. Further, pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the trading window of the Company shall stand closed from February 04, 2019 to February 13, 2019 (both days inclusive).